These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 31411082

  • 1. Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease.
    Ku E, Sarnak MJ, Toto R, McCulloch CE, Lin F, Smogorzewski M, Hsu CY.
    J Am Heart Assoc; 2019 Aug 20; 8(16):e012749. PubMed ID: 31411082
    [Abstract] [Full Text] [Related]

  • 2. Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk.
    Ku E, Bakris G, Johansen KL, Lin F, Sarnak MJ, Campese VM, Jamerson K, Gassman JJ, Smogorzewski M, Hsu CY.
    J Am Soc Nephrol; 2017 Sep 20; 28(9):2794-2801. PubMed ID: 28473636
    [Abstract] [Full Text] [Related]

  • 3. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
    Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG, African American Study of Kidney Disease and Hypertension Study Group.
    JAMA; 2002 Nov 20; 288(19):2421-31. PubMed ID: 12435255
    [Abstract] [Full Text] [Related]

  • 4. Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients.
    Aggarwal R, Petrie B, Bala W, Chiu N.
    Hypertension; 2019 Jun 20; 73(6):1275-1282. PubMed ID: 31067189
    [Abstract] [Full Text] [Related]

  • 5. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ, Zhang JH, Emanuele NV, Whaley-Connell A, Palevsky PM, Reilly RF, Guarino P, Fried LF, VA NEPHRON-D Study Group.
    Clin J Am Soc Nephrol; 2015 Dec 07; 10(12):2159-69. PubMed ID: 26482258
    [Abstract] [Full Text] [Related]

  • 6. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease.
    Ku E, Glidden DV, Johansen KL, Sarnak M, Tighiouart H, Grimes B, Hsu CY.
    Kidney Int; 2015 May 07; 87(5):1055-60. PubMed ID: 25493952
    [Abstract] [Full Text] [Related]

  • 7. Effects of Intensive BP Control in CKD.
    Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, Cushman WC, Hawfield AT, Johnson KC, Lewis CE, Oparil S, Rocco MV, Sink KM, Whelton PK, Wright JT, Basile J, Beddhu S, Bhatt U, Chang TI, Chertow GM, Chonchol M, Freedman BI, Haley W, Ix JH, Katz LA, Killeen AA, Papademetriou V, Ricardo AC, Servilla K, Wall B, Wolfgram D, Yee J, SPRINT Research Group.
    J Am Soc Nephrol; 2017 Sep 07; 28(9):2812-2823. PubMed ID: 28642330
    [Abstract] [Full Text] [Related]

  • 8. Blood pressure control, drug therapy, and kidney disease.
    Contreras G, Greene T, Agodoa LY, Cheek D, Junco G, Dowie D, Lash J, Lipkowitz M, Miller ER, Ojo A, Sika M, Wilkening B, Toto RD, African American Study of Kidney Disease and Hypertension Study Group Investigators.
    Hypertension; 2005 Jul 07; 46(1):44-50. PubMed ID: 15897360
    [Abstract] [Full Text] [Related]

  • 9. Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.
    Whittle J, Lynch AI, Tanner RM, Simpson LM, Davis BR, Rahman M, Whelton PK, Oparil S, Muntner P.
    Clin J Am Soc Nephrol; 2016 Mar 07; 11(3):471-80. PubMed ID: 26912544
    [Abstract] [Full Text] [Related]

  • 10. Acute Declines in Renal Function during Intensive BP Lowering and Long-Term Risk of Death.
    Ku E, Ix JH, Jamerson K, Tangri N, Lin F, Gassman J, Smogorzewski M, Sarnak MJ.
    J Am Soc Nephrol; 2018 Sep 07; 29(9):2401-2408. PubMed ID: 30006417
    [Abstract] [Full Text] [Related]

  • 11. Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).
    Grams ME, Li L, Greene TH, Tin A, Sang Y, Kao WH, Lipkowitz MS, Wright JT, Chang AR, Astor BC, Appel LJ.
    Am J Kidney Dis; 2015 Mar 07; 65(3):394-402. PubMed ID: 25441435
    [Abstract] [Full Text] [Related]

  • 12. Validation of chronic kidney disease risk categorization system in Chinese patients with kidney disease: A cohort study.
    Liu Q, Lv J, Li H, Jiao L, Yang H, Song Y, Xu G.
    Nephrology (Carlton); 2015 Dec 07; 20(12):936-44. PubMed ID: 26032648
    [Abstract] [Full Text] [Related]

  • 13. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
    Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.
    Am J Kidney Dis; 2000 Jun 07; 35(6):1155-65. PubMed ID: 10845831
    [Abstract] [Full Text] [Related]

  • 14. Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease.
    Bell EK, Gao L, Judd S, Glasser SP, McClellan W, Gutiérrez OM, Safford M, Lackland DT, Warnock DG, Muntner P.
    Am J Hypertens; 2012 Jul 07; 25(7):789-96. PubMed ID: 22573012
    [Abstract] [Full Text] [Related]

  • 15. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R, Gabbai FB, Chiodini P, Provenzano M, Borrelli S, Garofalo C, Bellizzi V, Russo D, Conte G, De Nicola L, Collaborative Study Group on the Conservative Treatment of CKD of the Italian Society of Nephrology.
    Am J Kidney Dis; 2020 Jan 07; 75(1):30-38. PubMed ID: 31409508
    [Abstract] [Full Text] [Related]

  • 16. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis.
    Lv J, Ehteshami P, Sarnak MJ, Tighiouart H, Jun M, Ninomiya T, Foote C, Rodgers A, Zhang H, Wang H, Strippoli GF, Perkovic V.
    CMAJ; 2013 Aug 06; 185(11):949-57. PubMed ID: 23798459
    [Abstract] [Full Text] [Related]

  • 17. Acute Declines in Estimated GFR in Blood Pressure Target Trials and Risk of Adverse Outcomes.
    Ku E, McCulloch CE, Copeland TP, Inker LA, Tighiouart H, Sarnak MJ.
    Am J Kidney Dis; 2023 Oct 06; 82(4):454-463. PubMed ID: 37269972
    [Abstract] [Full Text] [Related]

  • 18. APOL1 Risk Variants, Incident Proteinuria, and Subsequent eGFR Decline in Blacks with Hypertension-Attributed CKD.
    Chen TK, Tin A, Peralta CA, Appel LJ, Choi MJ, Lipkowitz MS, Winkler CA, Estrella MM.
    Clin J Am Soc Nephrol; 2017 Nov 07; 12(11):1771-1777. PubMed ID: 29051146
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.